» Articles » PMID: 34508571

Screening Health-Promoting Compounds for Their Capacity to Induce the Activity of FOXO3

Abstract

Several chemical compounds including natural products have been suggested as being effective against age-related diseases or as beneficial for a healthy life. On the other hand, forkhead box O (FOXO) proteins are emerging as key cellular components associated with extreme human longevity. FOXO proteins are mainly regulated by posttranslational modifications and as these modifications are reversible, activation and inactivation of FOXO are attainable through pharmacological treatment. Here, we questioned whether a panel of compounds with known health-beneficial properties has the capacity to induce the activity of FOXO factors. We show that resveratrol, a phytoalexin present in grapes and other food products, the amide alkaloid piperlongumine found in the fruit of the long pepper, and the plant-derived β-carboline compound harmine induced nuclear translocation of FOXO3. We also show that piperlongumine and harmine but not resveratrol activate FOXO-dependent transcription. We determined the half maximal effective concentration (EC50) values for resveratrol, piperlongumine, and harmine for FOXO translocation, and analyzed their inhibitory impact on chromosomal maintenance 1 (CRM1)-mediated nuclear export and the production of reactive oxygen species (ROS). We also used chemical biology approach and Western blot analysis to explore the underlying molecular mechanisms. We show that harmine, piperlongumine, and resveratrol activate FOXO3 independently of phosphoinositide 3-kinase (PI3K)/AKT signaling and the CRM1-mediated nuclear export. The effect of harmine on FOXO3 activity is at least partially mediated through the inhibition of dual-specificity tyrosine (Y) phosphorylationregulated kinase 1A (DYRK1A) and can be reverted by the inhibition of sirtuins (SIRTs).

Citing Articles

Use of Microfluidics for Study of FOXO3 Translocation Dynamics.

Perez J, Megias D Methods Mol Biol. 2024; 2871:155-161.

PMID: 39565586 DOI: 10.1007/978-1-0716-4217-7_14.


Reporter Gene Assays to Measure FOXO-Specific Transcriptional Activity.

Santos B, Orea-Soufi A, Mayoral-Varo V, Link W, Jimenez L Methods Mol Biol. 2024; 2871:45-53.

PMID: 39565577 DOI: 10.1007/978-1-0716-4217-7_5.


Geroscience and pathology: a new frontier in understanding age-related diseases.

Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A Pathol Oncol Res. 2024; 30:1611623.

PMID: 38463143 PMC: 10922957. DOI: 10.3389/pore.2024.1611623.


How can we modulate aging through nutrition and physical exercise? An epigenetic approach.

Rajado A, Silva N, Esteves F, Brito D, Binnie A, Araujo I Aging (Albany NY). 2023; 15(8):3191-3217.

PMID: 37086262 PMC: 10188329. DOI: 10.18632/aging.204668.


Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1-mediated nuclear export.

Jimenez L, Mayoral-Varo V, Amenabar C, Ortega J, Sequeira J, Machuqueiro M Traffic. 2022; 23(12):587-599.

PMID: 36353954 PMC: 10099545. DOI: 10.1111/tra.12872.


References
1.
Roy S, Srivastava R, Shankar S . Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 2010; 5:10. PMC: 2915986. DOI: 10.1186/1750-2187-5-10. View

2.
Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

3.
Link W . Introduction to FOXO Biology. Methods Mol Biol. 2018; 1890:1-9. DOI: 10.1007/978-1-4939-8900-3_1. View

4.
Machado S, Silva A, De Sousa-Coelho A, Duarte I, Grenho I, Santos B . Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance. Cancers (Basel). 2020; 12(12). PMC: 7763856. DOI: 10.3390/cancers12123689. View

5.
Calissi G, Lam E, Link W . Therapeutic strategies targeting FOXO transcription factors. Nat Rev Drug Discov. 2020; 20(1):21-38. DOI: 10.1038/s41573-020-0088-2. View